Orionis Biosciences

Foundation date

01-09-2015

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

We are an early stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical need – with an initial internal focus in oncology and immunotherapies.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    23 hours ago

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    23 hours ago

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    23 hours ago